Navigation Links
Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Date:9/4/2007

forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, difficulties or delays in transferring product manufacturing to the Goa facility; difficulties or delays in obtaining U.S. Food and Drug Administration or other regulatory approvals to manufacture products at the Goa, India site for the U.S. market; the impact of competitive products and pricing; market acceptance of and continued demand for Watson's products; difficulties or delays in manufacturing; and other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's Annual Report on Form 10-K for the year ended December 31, 2006.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO )


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. FDA approves Watson Pharmaceuticals Oxytrol patch
2. Pravastatin Launched by Watson Pharmaceuticals
3. Watson Amazed by Radcliffes Steamy Shots
4. Infant receives first bloodless liver transplant
5. Fifth US Patient Receives Artificial Heart
6. Northfield Labs Receives FDA Comments
7. British MPs Say Prostate Cancer Receives Low Priority in the NHS
8. Abbott Receives CE Mark Certification
9. Zactima Receives Fast Track Designation By The FDA
10. East London Receives World Class New Private Hospital Facility
11. Brinda Karat Receives Legal Notice over Ramdev Issue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 05, 2015 Hiliary Critchley, ... will present at the 24th Annual WEDI ... p.m. MT in Scottsdale, AZ. WEDI, the Workgroup ... nonprofit authority on the use of health IT ... Graf, National Director of Telemedicine for UnitedHealthcare will ...
(Date:5/5/2015)... 2015 From the halls of ... leader in enabling enterprise collaboration across platforms and ... speed up and simplify the move to Microsoft ... Solutions for Office 365 enable organizations to ... sustainable user adoption and effectively managing critical business ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great conditions ... and walkers participated in Global Lyme Alliance’s (GLA) inaugural ... The 5K and 10K runs and 1-and 3-mile walks were ... funds for tick-borne disease research. The “Lyme Walk and Run” ... of Lyme Research Alliance (LRA) and Tick-Borne Disease Alliance ...
(Date:5/5/2015)... May 05, 2015 " QuickPick Travel ” ... Report, which takes a look small, medium, and large businesses ... for NewsWatch and a business expert, conducted the business review ... to plan up to three weeks of vacation for free. ... and friends, and explore the world. And when people are ...
(Date:5/5/2015)... May 05, 2015 Information ... company serving the federal government, today announced its ... (CCSi). CCSi provides solutions exclusively to federal government ... experience in cyber security, health services, and program ... and industry-relevant credentials as a Third Party Assessment ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4
... www.harvesttech.com ) announced today that its new patient-education website, ... offer persons who are considering enrolling in the Company’s clinical ... study’s design, the science that underlies it, and the location ... ...
... quality of care for mothers and,babies, WASHINGTON, ... for mothers and newborns the National,Quality Forum endorsed ... received by mothers and babies during the third ... quality,of care by standardizing measurement in care settings ...
... A novel topical therapy for nail fungus, NB-002, ... fungus by penetrating skin pores and diffusing through the ... a study conducted by NanoBio Corporation. , The data ... which resists topical therapies because they cannot penetrate the ...
... buy-back program expects to collect 16 tons of candy, ... consumes more,than 24 pounds of candy per year, and ... For most people, this year,s candy noshing will,simply create ... million,North Americans in orthodontic treatment, Halloween treats can pose ...
... WOODCLIFF LAKE, N.J., Oct. 28 Par,Pharmaceutical Companies, Inc. (NYSE: ... call and live webcast on Friday, November 7, 2008 at ... September 27, 2008.,The Company will release results after the market ... available on the Par website,at http://www.parpharm.com ., Access ...
... announced that despite an overall increase in news reporting ... media coverage has become significantly more negative. "How the ... breast, colorectal and prostate cancer coverage, was an independent ... analyses were issued in 2000 and 2004. The report ...
Cached Medicine News:Health News: Harvest Technologies Announces Patient Education Website, www.CLIclinicalstudy.com : Supports first randomized, placebo-controlled clinical trial in the U.S. using autologous adult stem cells to treat patients with end-stage Critical Limb Ischemia 2Health News:National Quality Forum Endorses National Consensus Standards for Perinatal Care 2Health News:National Quality Forum Endorses National Consensus Standards for Perinatal Care 3Health News:New topical approach to treating nail fungus circumvents problems with current therapy 2Health News:Orthodontists Offer Sweet Incentives for Tricky Halloween Treats 2Health News:Orthodontists Offer Sweet Incentives for Tricky Halloween Treats 3Health News:Media coverage of lung cancer is increasing, and increasingly negative, new report shows 2
(Date:5/5/2015)... BRIDGEWATER, N.J. , May 5, 2015  CorMedix ... developing and commercializing therapeutic products for the treatment of ... 2015 financial results on May 7.  Randy Milby ... investor conference call on Friday, May 8 at 9:00 ... in the conference call, please call 1-877-407-8031 (U.S.), 1-201-689-8031 ...
(Date:5/5/2015)... 5, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... announced today that it will release its full financial results ... May 11 th before the open, followed by a ... results and business outlook. Participants should call (888) ... (International) and request the InspireMD call. A live webcast of ...
(Date:5/5/2015)... LONDON , May 5, 2015 ... or the "Company"), a biopharmaceutical company focused on ... proprietary cannabinoid product platform, announced today the closing ... Global Market by GW of 1,600,000 American Depositary ... ADS, raising gross proceeds of approximately $179.2 million ...
Breaking Medicine Technology:CorMedix, Inc. to Report First Quarter Financial Results on May 8, 2015 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4
... I system consists of four basic components: sample ... metal clamping plate (see diagram). The sample well ... spots, dots, or slots (see below). All three ... an accessory plate in conjunction with a complete ...
... Bio-Dot SF (slot format) microfiltration units provide ... nucleic acid in solution onto nitrocellulose or ... accommodated by using interchangeable templates to form ... format Bio-Dot SF apparatus. Each is available ...
... and Bio-Dot SF (slot format) microfiltration units ... or nucleic acid in solution onto nitrocellulose ... be accommodated by using interchangeable templates to ... slot format Bio-Dot SF apparatus. Each is ...
... clear, APET plastic tray. Ideal for staining ... trays used for multipurposes. Pour spouts in ... marker or label may be used for ... on rockers or shakers for staining several ...
Medicine Products: